Recently approved by the FDA, NULOJIX (belatacept) is an anti-rejection powder administered intravenously to adult kidney and pediatric transplant patients.


Learn more about Metro Infusion Center's unique, compassionate approach to care and why patients continue to choose Metro Infusion Center for all their infusion needs.


INFUSION THERAPIES PROVIDED


ACTEMRA


ANTIBIOTICS


BENLYSTA


CIMZIA


ENTYVIO


FABRAZYME


IVIG


IV STEROIDS


NULOJIX


ORENCIA


PROLIA


REMICADE


RITUXAN


SIMPONI ARIA


TYSABRI


XOLAIR


INFUSION THERAPIES: NULOJIX

If your physician has prescribed NULOJIX as part of your transplant recovery regimen, Metro Infusion Center can help.

NULOJIX is a type of drug called a selective T-cell costimulation blocker. It helps to prevent organ rejection after a kidney transplant.

Without immunosuppression, the body can reject a transplanted organ because the immune system recognizes the new organ as foreign (transplant rejection). Given through 30-minute intravenous infusions, NULOJIX works with other immunosuppressants to prevent rejection and keep the new kidney working.

CALL 877.448.3627 FOR MORE INFORMATION OR TO SCHEDULE AN APPOINTMENT.